The power and promise of personalized medicine: a genetic test can reduce cardiovascular risk for some heart patients.
A UAB study will test whether training to modify care-resistant behavior can improve quality of life for family caregivers of dementia patients.
UAB and Auburn will team up for a study of magnetic resonance imaging techniques that could enhance epilepsy surgery.
UAB investigators have won a prestigious White House BRAIN Initiative grant to study the potential benefits of new technology coupled with newly discovered biomarkers in deep brain stimulation for Parkinson’s disease.
UAB and partners launch the PREVeNT study, aimed at preventing the onset of seizures in children with tuberous sclerosis.
A UAB study sheds light on and suggests a target for treatment of a variant of Guillain-Barré syndrome.
An NIH grant will help support personalized medicine and patient-oriented research at UAB.
The mechanism of widespread reorganization of DNA methylation may be a therapeutic target to prevent or reverse dyskinesia.
Researchers have found that an interaction between a mutant gene and alpha synuclein in neurons leads to hallmark pathologies seen in Parkinson’s disease, findings that may lead to new mechanisms and targets for neuroprotection.
The biomarker, the protein kinase LRRK2, is a promising candidate for future exploration.
Page 3 of 9